WallStreetZenWallStreetZen

NASDAQ: ACTU
Actuate Therapeutics Inc Stock Ownership - Who owns Actuate Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Actuate Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Bios Equity Cof LPDirector2025-06-2771,428$7.00
$500.00kBuy
Aaron Gl FletcherDirector2025-06-2771,428$7.00
$500.00kBuy
Leslie W. KreisDirector2025-06-2771,428$7.00
$500.00kBuy

1 of 1

ACTU insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ACTU insiders and whales buy or sell their stock.

ACTU Shareholders

What type of owners hold Actuate Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Bios Equity Cof LP49.15%10,196,456$65.77MInsider
Leslie W. Kreis49.15%10,196,456$65.77MInsider
Aaron Gl Fletcher49.15%10,196,456$65.77MInsider
Bios Capital Management LP48.04%9,965,079$64.27MInstitution
Voss Capital LP1.38%286,140$1.85MInstitution
Vanguard Group Inc1.27%264,464$1.71MInstitution
Blackrock Inc0.94%195,452$1.26MInstitution
Geode Capital Management LLC0.57%118,050$761.42kInstitution
Northern Trust Corp0.41%85,694$552.73kInstitution
Barclays PLC0.18%37,334$240.80kInstitution

1 of 3

ACTU vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ACTU26.83%73.17%Net Buying
MCRB3.29%96.71%Net SellingNet Selling
CLYM73.63%9.49%Net Selling
ABOS62.08%17.23%Net Selling
ANIX16.25%82.80%Net Buying
View Top Biotech Stocks

Actuate Therapeutics Stock Ownership FAQ

Who owns Actuate Therapeutics?

Actuate Therapeutics (NASDAQ: ACTU) is owned by 54.07% institutional shareholders, 147.45% Actuate Therapeutics insiders, and 0.00% retail investors. Bios Equity Cof LP is the largest individual Actuate Therapeutics shareholder, owning 10.20M shares representing 49.15% of the company. Bios Equity Cof LP's Actuate Therapeutics shares are currently valued at $67.09M.

If you're new to stock investing, here's how to buy Actuate Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.